153 related articles for article (PubMed ID: 27086168)
1. A sustained release formulation of novel quininib-hyaluronan microneedles inhibits angiogenesis and retinal vascular permeability in vivo.
Galvin O; Srivastava A; Carroll O; Kulkarni R; Dykes S; Vickers S; Dickinson K; Reynolds AL; Kilty C; Redmond G; Jones R; Cheetham S; Pandit A; Kennedy BN
J Control Release; 2016 Jul; 233():198-207. PubMed ID: 27086168
[TBL] [Abstract][Full Text] [Related]
2. Phenotype-based Discovery of 2-[(E)-2-(Quinolin-2-yl)vinyl]phenol as a Novel Regulator of Ocular Angiogenesis.
Reynolds AL; Alvarez Y; Sasore T; Waghorne N; Butler CT; Kilty C; Smith AJ; McVicar C; Wong VH; Galvin O; Merrigan S; Osman J; Grebnev G; Sjölander A; Stitt AW; Kennedy BN
J Biol Chem; 2016 Apr; 291(14):7242-55. PubMed ID: 26846851
[TBL] [Abstract][Full Text] [Related]
3. Discovery and Development of the Quininib Series of Ocular Drugs.
Mahon N; Slater K; O'Brien J; Alvarez Y; Reynolds A; Kennedy B
J Ocul Pharmacol Ther; 2022; 38(1):33-42. PubMed ID: 35089801
[TBL] [Abstract][Full Text] [Related]
4. A Quininib Analogue and Cysteinyl Leukotriene Receptor Antagonist Inhibits Vascular Endothelial Growth Factor (VEGF)-independent Angiogenesis and Exerts an Additive Antiangiogenic Response with Bevacizumab.
Butler CT; Reynolds AL; Tosetto M; Dillon ET; Guiry PJ; Cagney G; O'Sullivan J; Kennedy BN
J Biol Chem; 2017 Mar; 292(9):3552-3567. PubMed ID: 28035003
[TBL] [Abstract][Full Text] [Related]
5. Preclinical validation of the small molecule drug quininib as a novel therapeutic for colorectal cancer.
Murphy AG; Casey R; Maguire A; Tosetto M; Butler CT; Conroy E; Reynolds AL; Sheahan K; O'Donoghue D; Gallagher WM; Fennelly D; Kennedy BN; O'Sullivan J
Sci Rep; 2016 Oct; 6():34523. PubMed ID: 27739445
[TBL] [Abstract][Full Text] [Related]
6. Exosome-mediated delivery of an anti-angiogenic peptide inhibits pathological retinal angiogenesis.
Dong X; Lei Y; Yu Z; Wang T; Liu Y; Han G; Zhang X; Li Y; Song Y; Xu H; Du M; Yin H; Wang X; Yan H
Theranostics; 2021; 11(11):5107-5126. PubMed ID: 33859737
[No Abstract] [Full Text] [Related]
7. Studies with an orally bioavailable alpha V integrin antagonist in animal models of ocular vasculopathy: retinal neovascularization in mice and retinal vascular permeability in diabetic rats.
Santulli RJ; Kinney WA; Ghosh S; Decorte BL; Liu L; Tuman RW; Zhou Z; Huebert N; Bursell SE; Clermont AC; Grant MB; Shaw LC; Mousa SA; Galemmo RA; Johnson DL; Maryanoff BE; Damiano BP
J Pharmacol Exp Ther; 2008 Mar; 324(3):894-901. PubMed ID: 18083913
[TBL] [Abstract][Full Text] [Related]
8. A novel small molecule ameliorates ocular neovascularisation and synergises with anti-VEGF therapy.
Sulaiman RS; Merrigan S; Quigley J; Qi X; Lee B; Boulton ME; Kennedy B; Seo SY; Corson TW
Sci Rep; 2016 May; 6():25509. PubMed ID: 27148944
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal anti-VEGF therapy blocks inflammatory cell infiltration and re-entry into the circulation in retinal angiogenesis.
Nakao S; Arima M; Ishikawa K; Kohno R; Kawahara S; Miyazaki M; Yoshida S; Enaida H; Hafezi-Moghadam A; Kono T; Ishibashi T
Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):4323-8. PubMed ID: 22661475
[TBL] [Abstract][Full Text] [Related]
10. Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model.
Ayalasomayajula SP; Kompella UB
Eur J Pharmacol; 2005 Mar; 511(2-3):191-8. PubMed ID: 15792788
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of bestatin in the retina of streptozotocin-induced diabetic mice.
Hossain A; Heron D; Davenport I; Huckaba T; Graves R; Mandal T; Muniruzzaman S; Wang S; Bhattacharjee PS
Exp Eye Res; 2016 Aug; 149():100-106. PubMed ID: 27344955
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal thalidomide reduces experimental preretinal neovascularisation without induction of retinal toxicity.
Vom Hagen F; Kamppeter BA; Erber R; Jonas JB; Hammes HP
Br J Ophthalmol; 2010 Apr; 94(4):504-8. PubMed ID: 19713194
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of diclofenac formulated in hyaluronan on angiogenesis in vitro and its intraocular tolerance in the rabbit eye.
Shen WY; Constable IJ; Chelva E; Rakoczy PE
Graefes Arch Clin Exp Ophthalmol; 2000 Mar; 238(3):273-82. PubMed ID: 10796042
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E2 and E3, but Not E4, Promote Retinal Pathologic Neovascularization.
Masuda T; Shimazawa M; Hashimoto Y; Kojima A; Nakamura S; Suemori S; Mochizuki K; Kawakami H; Kawase K; Hara H
Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):1208-1217. PubMed ID: 28241308
[TBL] [Abstract][Full Text] [Related]
15. In situ antibody-loaded hydrogel for intravitreal delivery.
Awwad S; Abubakre A; Angkawinitwong U; Khaw PT; Brocchini S
Eur J Pharm Sci; 2019 Sep; 137():104993. PubMed ID: 31302214
[TBL] [Abstract][Full Text] [Related]
16. Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbits.
Alikacem N; Yoshizawa T; Nelson KD; Wilson CA
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1561-9. PubMed ID: 10798677
[TBL] [Abstract][Full Text] [Related]
17. The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity.
Penn JS; Rajaratnam VS; Collier RJ; Clark AF
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):283-90. PubMed ID: 11133880
[TBL] [Abstract][Full Text] [Related]
18. Zebrafish (Danio rerio) embryo as a platform for the identification of novel angiogenesis inhibitors of retinal vascular diseases.
Rezzola S; Paganini G; Semeraro F; Presta M; Tobia C
Biochim Biophys Acta; 2016 Jul; 1862(7):1291-6. PubMed ID: 27085972
[TBL] [Abstract][Full Text] [Related]
19. Anti-Flt1 peptide - hyaluronate conjugate for the treatment of retinal neovascularization and diabetic retinopathy.
Oh EJ; Choi JS; Kim H; Joo CK; Hahn SK
Biomaterials; 2011 Apr; 32(11):3115-23. PubMed ID: 21277020
[TBL] [Abstract][Full Text] [Related]
20. Anisotropic poly(lactic-co-glycolic acid) microparticles enable sustained release of a peptide for long-term inhibition of ocular neovascularization.
Kim J; Lima E Silva R; Shmueli RB; Mirando AC; Tzeng SY; Pandey NB; Ben-Akiva E; Popel AS; Campochiaro PA; Green JJ
Acta Biomater; 2019 Oct; 97():451-460. PubMed ID: 31374338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
